P4DETECT COVID-19 IgM/IgG
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- diagnosic kits, rapid test, test kit, covid 19
- Category
- Medical Test Kit
South Korea
| Product name | P4DETECT COVID-19 IgM/IgG | Certification | - |
|---|---|---|---|
| Category | Medical Test Kit | Ingredients | - |
| Keyword | diagnosic kits , rapid test , test kit , covid 19 | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | South Korea | Stock | - |
| Supply type | - | HS code | - |
Product Information
P4DETECT COVID-19 IgM/IgG
Rapid chromatographic immunoassay for the qualitative detection of Coronavirus(SARS-CoV-2) IgM and IgG antibody in serum, plasma and whole blood specimens.
- Immunochromatography based one-step in vitro diagnostic test
- No instruments needed
- Specimen: Serum, plasma, whole blood
- Reading Time: 10~15 min
Additional information
MOQ: 100 test
Annual supply capacity: 100,000 EA Pieces per Week
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
- President
- OH KYUHA
- Address
- 930 415 Heungan daero 14059, Dongan-gu, Anyang-si, Gyeonggi-do, Korea
- Product Category
- Medical Test Kit
- Year Established
- 2016
- No. of Total Employees
- 1-50
- Company introduction
-
PRIME4DIA is R&D group and manufacturer for in vitro diagnostic products from Republic of Korea. PRIME4DIA is focusing its efforts on Point of Care Testing (POCT) as its core strategic business. Our R&D center and factory located at Anyang city, nearby Seoul, is an up-to-dated manufacturing facility equipped to produce monoclonal antibody, antigen, gold nanoparticle and wide range of rapid tests (semi-finished products).
- Main Markets
-
Brazil
India
Indonesia
Kazakhstan
Malaysia
Peru
Russia
South Africa
- Main Product
